CTOs on the Move

Alnylam

www.alnylam.com

 
Alnylam is the world`s leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market. We are developing RNAi (RNA interference) as an innovative, entirely new class of medicines to treat rare genetic, cardio metabolic, acute hepatic infectious and central nervous system (CNS) and ocular diseases. Alnylam was founded in 2002 based on a Nobel Prize-winning breakthrough in biology – the discovery of RNAi, and a bold vision that this discovery could be used to silence disease-causing genes upstream of today`s medicines. We are relentless in our pursuit of new treatments because we believe ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.alnylam.com
  • 300 Third Street 3rd Floor
    Cambridge, MA USA 02142
  • Phone: 617.551.8200

Executives

Name Title Contact Details
Radu Morar
IT Associate Director Profile
Sanju Misra
VP, Information Security Profile

Funding

Alnylam raised $800M on 04/08/2019
Alnylam raised $750M on 04/13/2020

Similar Companies

Colorado Health Care Association

Colorado Health Care Association is a Denver, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

OccHealth Systems

OccHealth Systems is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Vantage Holding Company

Vantage Holding Company is a Meadville, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bayside Manor

Bayside Manor is a Keansburg, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Heartbeat Experts

Heartbeat Experts is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.